Synergy of an Investigational Glycopeptide, LY333328, with Once-Daily Gentamicin against Vancomycin-Resistant Enterococcus faecium in a Multiple-Dose, In Vitro Pharmacodynamic Model

The pharmacodynamics of an investigational glycopeptide, LY333328 (LY), alone and in combination with gentamicin, against one vancomycin-susceptible and two vancomycin-resistant Enterococcus faecium strains were studied with a multiple-dose, in vitro pharmacodynamic model (PDM). Dose-range data for...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Zelenitsky, S. A., Booker, B., Laing, N., Karlowsky, J. A., Hoban, D. J., Zhanel, G. G.
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 1999
主題:	Pharmacology
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89165/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10049272/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.3.592
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!